In cohort II, the tumor-bearing mice fed with glucomannan in 2 and 4 mg doses showed a significant IFN-γ cytokine increase compared to the cyclophosphamide group (p < 0.005), while those fed 4 mg glucomannan showed a significant increase compared to the PBS control group (p = 0.0038). Here, IFNG is linked to neoplasm.